on 4 Dec 2024
TM5 Status
LIVE/APPLICATION/ Published for Opposition
Your application has been published for opposition.
Last Applicant/ Owned by
Confo Therapeutics N.V.
Technologiepark 94B-9052 Zwijnaarde
BE
Serial Number
2171676 filed on 10th Jan 2022
Correspondent Address
FASKEN MARTINEAU DUMOULIN LLP
333 BAY STREET, SUITE 2400BAY ADELAIDE CENTRE, BOX 20TORONTO
ONTARIO
CA
M5H2T6
Trademark usage description
cell culture reagents for scientific laboratory use; biochemicals in the form of g protein-coupled receptors (gpcrs) for in vitro and in vivo scientif Read More11
11
2171676
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 22 on 29th Jun 2023 | Search Recorded |
Submitted for opposition 20 on 29th Jun 2023 | Examiner's First Report |
Submitted for opposition 223 on 29th Jun 2023 | Total Provisional Refusal |
Submitted for opposition 256 on 10th Jan 2023 | Notification of Possible Opposition Sent |
Submitted for opposition 48 on 2th Jun 2022 | Agent Changed |
Submitted for opposition 257 on 10th Mar 2022 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 9th Mar 2022 | Created |
Submitted for opposition 31 on 9th Mar 2022 | Formalized |
Submitted for opposition 30 on 10th Jan 2022 | Filed |
Submitted for opposition 228 on 10th Jan 2022 | International Registration |